The ins and outs of fibroblast growth factor receptor signalling

Stacey J Coleman1, Charo Bruce1, Athina-Myrto Chioni1

  • 1*Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, U.K.

Insights

Fibroblast growth factor receptor (FGFR) signaling is crucial in cancer. This review highlights FGFR

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • Fibroblast growth factor receptor (FGFR) signaling is vital in development, physiology, and disease, particularly in various cancers.
  • While canonical downstream pathways in cancer cells are understood, emerging research points to FGFR's roles in stromal interactions and the nucleus.
  • The tumor microenvironment (stroma) is recognized for its influence on cancer progression and treatment response.

Purpose of the Study:

  • To review emerging research on fibroblast growth factor receptor (FGFR) signaling in cancer.
  • To focus on two under-explored areas: FGFR's role in cancer-associated stromal cross-talk and its potential functions within the cell nucleus.
  • To underscore the clinical relevance and interconnectedness of these FGFR signaling aspects, especially in pancreatic cancer.

Main Methods:

  • Literature review of recent studies on fibroblast growth factor receptor (FGFR) signaling in cancer.
  • Synthesis of evidence regarding FGFR's involvement in stromal interactions and nuclear functions.
  • Analysis of clinical implications and potential therapeutic targeting strategies.

Main Results:

  • FGFR signaling significantly influences cancer progression through cross-talk with the tumor stroma.
  • Evidence suggests FGFR signaling pathways operate within the cell nucleus, impacting cancer biology.
  • These stromal and nuclear roles of FGFR are clinically relevant and interconnected, notably in pancreatic cancer.

Conclusions:

  • Emerging evidence highlights the critical, yet underappreciated, roles of fibroblast growth factor receptor (FGFR) signaling in cancer progression via stromal interactions and nuclear functions.
  • Further investigation into these areas offers promising avenues for novel cancer therapies, particularly targeting receptor tyrosine kinases.
  • The study emphasizes the need to consider FGFR's broader biological context beyond cancer cells for effective therapeutic strategies.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K